The Case for Bladder Botulinum Toxin Application

Urologic Clinics of North America

Volumn 33, Issue 4, 2006, Pages 503-510

  Kim, Dae Kyung ^a   Thomas, Catherine A ^b   Smith, Christopher ^b   Chancellor, Michael B ^b  

^a Eulji University School of Medicine   (South Korea)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR; RESINIFERATOXIN;

ABSENCE OF SIDE EFFECTS; ANTICHOLINERGIC EFFECT; ANTINOCICEPTION; AUTONOMIC NERVOUS SYSTEM; BLADDER COMPLIANCE; CHILD CARE; CHOLINERGIC ACTIVITY; CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; EXPERIMENTAL RAT; HUMAN; IDIOPATHIC DISEASE; MECHANORECEPTOR; MENINGOMYELOCELE; NEUROGENIC BLADDER; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; URODYNAMICS; VESICOURETERAL REFLUX;

ADMINISTRATION, INTRAVESICAL; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; BOTULINUM TOXINS, TYPE A; HUMANS; NEUROMUSCULAR AGENTS; URINARY BLADDER, OVERACTIVE;

EID: 33748965171     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2006.06.010     Document Type: Review

References (46)

1. Erbguth F.J. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 19 8 (2004) S2-S6
2. Petit H., Wiart E., Gaujard E., et al. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36 2 (1998) 91-94
3. Dykstra D.D., and Sidi A. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double blind study. Arch Phys Med Rehabil 71 1 (1990) 24-26
4. Dykstra D.D., Sidi A.A., Scott A.B., et al. Effects of botulinum A toxin on detrusor-sphincter dyssyngeria in spinal cord injury patients. J Urol 139 5 (1988) 919-922
5. Chancellor M.B., and de Groat W.C. Intravesical capsaicin and resiniferatoxin: spicing up the ways to treat the overactive bladder. J Urol 162 1 (1999) 3-11
6. Stohrer M., Schurch B., Kramer G., et al. Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures?. Neurourol Urodyn 18 4 (1999) 401
7. Schurch B., Stohrer M., Kramer G., et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164 (2000) 692-697
8. Del Popolo G. Botulinum-A toxin in the treatment of detrusor hyperreflexia. [abstract]. Neurourol Urodyn 20 4 (2001) 522-524
9. Heckmann M., Ceballos-Baumann A.O., and Plewig G. Hyperhidrosis study group: botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344 7 (2001) 488-493
10. Porta M., Gamba M., Bertacchi G., et al. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 70 4 (2001) 538-540
11. Von Lindern J.J., Niederhagen B., Berge S., et al. Frey syndrome: treatment with type A botulinum toxin. Cancer 89 8 (2000) 1659-1663
12. Schurch B., Stöhrer M., Kramer G., et al. Botulinum toxin-A to treat detrusor hyperreflexia in spinal cord injured patients. [abstract]. Neurourol Urodyn 20 4 (2001) 521-522
13. Reitz A., Stohrer M., Kramer G., et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45 (2004) 510-515
14. Klaphajone J., Kitisomprayoonkul W., and Sriplakit S. Botulinum toxin type A for treating neurogenic detrusor overactivty combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys Med Rehabil 86 (2005) 2114-2118
15. Schurch B., de Seze M., Denys P., et al. Botulinum-A toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174 (2005) 196-200
16. Schulte-Baukloh H., Michael T., Sturzebecher B., et al. Botulinum A-toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44 (2003) 139-143
17. Riccabona M., Koen M., Schindler M., et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171 (2004) 845-848
18. Giannantoni A., Di Stasi S.M., Stephen R.L., et al. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172 (2004) 240-243
19. de Paiva A., Meunier F.A., Molgo J., et al. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96 6 (1999) 3200-3205
20. Greene P., Fahn S., and Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 9 2 (1994) 213-217
21. Jankovic J., Vuong K.D., and Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60 7 (2003) 1186-1188
22. Whelchel D.D., Brehmer T.M., Brooks P.M., et al. Molecular targets of botulinum toxin at the mammalian neuromuscular junction. Mov Disord 19 Suppl 8 (2004) S7-S16
23. Haferkamp A., Schurch B., Reitz A., et al. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. Eur Urol 46 6 (2004) 784-791
24. Grosse J.O., Kramer G., Lochner-Ernst D., et al. Outcome of repeat detrusor injections of botulinum A toxin (BTX-A) for severe neurogenic detrusor overactivity and incontinence. J Urol 169 4 Suppl (2003) 373
25. Schulte-Baukloh H., Knispel H.H., Stolze T., et al. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66 4 (2005) 865-870 [discussion: 870]
26. Radziszewski P., Dobronski P., and Borkowski A. Treatment of the non-neurogenic storage and voiding disorders with the chemical denervation caused by botulinum toxin type A-a pilot study. [abstract]. Neurourol Urodyn 20 4 (2001) 410-412
27. Zermann D.H., Ishigooka M., Schubert J., et al. Trigonum and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency-syndrome refractory to conservative medical treatment and electrical stimulation. [abstract]. Neurourol Urodyn 20 4 (2001) 412-413
28. Loch A., Loch T., Osterhage J., et al. Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence. J Urol 169 4 Suppl (2003) 124
29. Smith C.P., Nishiguchi J., O'Leary M., et al. Single institution experience in 110 patients with botulinum toxin-A injection into the bladder or urethra. Urology 65 (2005) 37-41
30. Rapp D.E., Lucioni A., Katz E.E., et al. Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 63 (2004) 1071-1075
31. Werner M., Schmid D.M., and Schussler B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 192 5 (2005) 1735-1740
32. Kessler T.M., Danuser H., Schumacher M., et al. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?. Neurourol Urodyn 24 3 (2005) 231-236
33. Popat R., Apostolidis A., Kalsi V., et al. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174 3 (2005) 984-989
34. Dykstra D., Enriquez A., and Valley M. Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int Urogynecol J 14 (2003) 424-426
35. Smith C.P., Franks M.E., McNeil B.K., et al. Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 169 5 (2003) 1896-1900
36. Somogyi G.T., Zernova G.V., Yoshiyama M., et al. Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats. Br J Pharmacol 125 2 (1998) 241-246
37. Hawthorn M.H., Chapple C.R., Cock M., et al. Urothelium-derived inhibitory factor(s) influence detrusor muscle contractility in vitro. Br J Pharmacol 129 (2000) 416-419
38. Wakabayashi Y., Kojima Y., Makiura Y., et al. Free terminal fibers of autonomic nerves in the mucosa of the cat urinary bladder. In: Wegmann R.J., and Wegmann M.A. (Eds). Recent advances in cellular and molecular biology, vol. 3 (1991), Peeters Press, Leuven, Belgium 109-117
39. Wakabayashi Y., Kojima Y., Makiura Y., et al. Acetylcholinesterase positive axons in the mucosa of urinary bladder of adult cats: retrograde tracing and degeneration studies. Histol Histopathol 10 (1995) 523-530
40. Andersson K.E., and Yoshida M. Antimuscarinics and the overactive detrusor-which is the main mechanism of action?. Eur Urol 43 1 (2003) 1-5
41. Smith C.P., Boone T.B., de Groat W.C., et al. Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull 61 (2003) 165-171
42. O'Reilly B.A., Kosaka A.H., Knight G.F., et al. P2X receptors and their role in female idiopathic detrusor instability. J Urol 167 (2002) 157-164
43. Cui M., Khanijou S., Rubino J., et al. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107 1-2 (2004) 125-133
44. Vemulakonda V.M., Somogyi G.T., Kiss S., et al. Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation. J Urol 173 2 (2005) 621-624
45. Smith C.P., and Chancellor M.B. Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171 (2004) 2128-2137
46. Khera M., Somogyi G.T., Kiss S., et al. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45 (2004) 987-993